Tigecycline in critical care Article

Full Text via DOI: 10.1016/j.ccc.2007.12.007 PMID: 18361951 Web of Science: 000255230400010

Cited authors

  • Mullangi, Praveen K.; Pankey, George A.


  • The emergence and spread of multidrug resistance in many pathogenic bacterial species is increasing at an alarming rate, especially with hospital-acquired infections in the critical care setting. Deaths associated with hospital-acquired infections have exceeded the number attributable to several of the top 10 leading causes of death reported in the United States. The emerging resistance limits the use of older antibiotics. Tigecycline is a new agent, and this article explores its role in the treatment of adults in the critical care setting.

Publication date

  • 2008

Published in


International Standard Serial Number (ISSN)

  • 0749-0704

Start page

  • 365


  • 24


  • 2